612 related articles for article (PubMed ID: 21597004)
1. Endothelial microparticle formation by angiotensin II is mediated via Ang II receptor type I/NADPH oxidase/ Rho kinase pathways targeted to lipid rafts.
Burger D; Montezano AC; Nishigaki N; He Y; Carter A; Touyz RM
Arterioscler Thromb Vasc Biol; 2011 Aug; 31(8):1898-907. PubMed ID: 21597004
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II induces capillary formation from endothelial cells via the LOX-1 dependent redox-sensitive pathway.
Hu C; Dandapat A; Mehta JL
Hypertension; 2007 Nov; 50(5):952-7. PubMed ID: 17893372
[TBL] [Abstract][Full Text] [Related]
3. Rho/Rho kinase is a key enzyme system involved in the angiotensin II signaling pathway of liver fibrosis and steatosis.
Kitamura K; Tada S; Nakamoto N; Toda K; Horikawa H; Kurita S; Tsunematsu S; Kumagai N; Ishii H; Saito H; Hibi T
J Gastroenterol Hepatol; 2007 Nov; 22(11):2022-33. PubMed ID: 17914985
[TBL] [Abstract][Full Text] [Related]
4. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis.
Wang YX; Martin-McNulty B; da Cunha V; Vincelette J; Lu X; Feng Q; Halks-Miller M; Mahmoudi M; Schroeder M; Subramanyam B; Tseng JL; Deng GD; Schirm S; Johns A; Kauser K; Dole WP; Light DR
Circulation; 2005 May; 111(17):2219-26. PubMed ID: 15851596
[TBL] [Abstract][Full Text] [Related]
5. Arterial and venous endothelia display differential functional fractalkine (CX3CL1) expression by angiotensin-II.
Rius C; Piqueras L; González-Navarro H; Albertos F; Company C; López-Ginés C; Ludwig A; Blanes JI; Morcillo EJ; Sanz MJ
Arterioscler Thromb Vasc Biol; 2013 Jan; 33(1):96-104. PubMed ID: 23117657
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Rho-kinase protects cerebral barrier from ischaemia-evoked injury through modulations of endothelial cell oxidative stress and tight junctions.
Gibson CL; Srivastava K; Sprigg N; Bath PM; Bayraktutan U
J Neurochem; 2014 Jun; 129(5):816-26. PubMed ID: 24528233
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
8. Androgens potentiate renal vascular responses to angiotensin II via amplification of the Rho kinase signaling pathway.
Song J; Kost CK; Martin DS
Cardiovasc Res; 2006 Dec; 72(3):456-63. PubMed ID: 17049502
[TBL] [Abstract][Full Text] [Related]
9. Apocynin-induced vasodilation involves Rho kinase inhibition but not NADPH oxidase inhibition.
Schlüter T; Steinbach AC; Steffen A; Rettig R; Grisk O
Cardiovasc Res; 2008 Nov; 80(2):271-9. PubMed ID: 18596059
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1-7 in experimental heart failure in angiotensin-converting enzyme 2-null mice.
Patel VB; Bodiga S; Fan D; Das SK; Wang Z; Wang W; Basu R; Zhong J; Kassiri Z; Oudit GY
Hypertension; 2012 Jun; 59(6):1195-203. PubMed ID: 22508831
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II impairs neurovascular coupling in neocortex through NADPH oxidase-derived radicals.
Kazama K; Anrather J; Zhou P; Girouard H; Frys K; Milner TA; Iadecola C
Circ Res; 2004 Nov; 95(10):1019-26. PubMed ID: 15499027
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin II-induced upregulation of SGLT1 and 2 contributes to human microparticle-stimulated endothelial senescence and dysfunction: protective effect of gliflozins.
Park SH; Belcastro E; Hasan H; Matsushita K; Marchandot B; Abbas M; Toti F; Auger C; Jesel L; Ohlmann P; Morel O; Schini-Kerth VB
Cardiovasc Diabetol; 2021 Mar; 20(1):65. PubMed ID: 33726768
[TBL] [Abstract][Full Text] [Related]
13. Irbesartan inhibits advanced glycation end product (AGE)-induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) mRNA levels in glomerular endothelial cells.
Matsui T; Nishino Y; Maeda S; Takeuchi M; Yamagishi S
Microvasc Res; 2011 May; 81(3):269-73. PubMed ID: 21236267
[TBL] [Abstract][Full Text] [Related]
14. Microtubules regulate angiotensin II type 1 receptor and Rac1 localization in caveolae/lipid rafts: role in redox signaling.
Zuo L; Ushio-Fukai M; Hilenski LL; Alexander RW
Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1223-8. PubMed ID: 15142861
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.
Montezano AC; Burger D; Paravicini TM; Chignalia AZ; Yusuf H; Almasri M; He Y; Callera GE; He G; Krause KH; Lambeth D; Quinn MT; Touyz RM
Circ Res; 2010 Apr; 106(8):1363-73. PubMed ID: 20339118
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 is essential for activation of Rac1 and NAD(P)H oxidase after angiotensin II type 1 receptor stimulation in vascular smooth muscle cells: role in redox signaling and vascular hypertrophy.
Zuo L; Ushio-Fukai M; Ikeda S; Hilenski L; Patrushev N; Alexander RW
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1824-30. PubMed ID: 15976327
[TBL] [Abstract][Full Text] [Related]
17. TLR4 is a critical regulator of angiotensin II-induced vascular remodeling: the roles of extracellular SOD and NADPH oxidase.
Nakashima T; Umemoto S; Yoshimura K; Matsuda S; Itoh S; Murata T; Fukai T; Matsuzaki M
Hypertens Res; 2015 Oct; 38(10):649-55. PubMed ID: 25854990
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Rho-kinase by fasudil attenuated angiotensin II-induced cardiac hypertrophy in apolipoprotein E deficient mice.
Wang YX; da Cunha V; Martin-McNulty B; Vincelette J; Li W; Choy DF; Halks-Miller M; Mahmoudi M; Schroeder M; Johns A; Light DR; Dole WP
Eur J Pharmacol; 2005 Apr; 512(2-3):215-22. PubMed ID: 15840407
[TBL] [Abstract][Full Text] [Related]
19. ClC-3 deficiency prevents apoptosis induced by angiotensin II in endothelial progenitor cells via inhibition of NADPH oxidase.
Liu J; Zhang FF; Li L; Yang J; Liu J; Guan YY; Du YH
Apoptosis; 2013 Oct; 18(10):1262-73. PubMed ID: 23873092
[TBL] [Abstract][Full Text] [Related]
20. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
